⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Connect
accessnewswire.com
ALDX
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ALDX
Form 8-K
sec.gov
ALDX
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
businesswire.com
ALDX
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
businesswire.com
ALDX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Pomerantz LLP – ALDX
accessnewswire.com
ALDX
Pomerantz LLP Notifies Shareholders of Lawsuit Filed Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX